🧬 Predict. Prevent. Protect: The APOL1 Proteomic Revolution

A fascinating new study in Nature Medicine describes a 9-protein APOL1 Proteomic Risk Score (APRS) capable of predicting kidney disease progression years before chronic kidney disease becomes clinically apparent.

Among individuals of African ancestry with APOL1 high-risk genotypes and preserved kidney function, APRS achieved a remarkable time-dependent AUC of ~86%, substantially outperforming traditional clinical scores and polygenic risk tools.

This work moves us closer to precision nephrology: identifying who is truly at risk, enriching clinical trials, and potentially guiding targeted therapies such as inaxaplin.

A powerful example of proteomics transforming static genetic risk into dynamic clinical prediction. 🔬🩺

Li C et al. Nature Medicine. 2026. doi:10.1038/s41591-026-04337

🧠🎙️ New infographic from Dr RR Baliga's Podkast for the Kurious Doc: "Colonoscopy, Cancer & Competing Risks."

Two major 2026 studies from The Lancet and JAMA reshape how we think about colorectal cancer screening and surveillance.

🔹 The NordICC trial showed reduced colorectal cancer incidence with colonoscopy, but no significant mortality reduction after 13 years. 🔹 In adults ≥75 years with prior adenomas, non-colorectal cancer mortality far exceeded colorectal cancer risk, highlighting the importance of frailty and individualized decision-making.

Key lesson: the future of colon cancer screening is not "more colonoscopies," but smarter, patient-centered precision prevention. 🎯

#ColorectalCancer #Colonoscopy #CancerPrevention #Gastroenterology #PrecisionMedicine #Frailty #JAMA #Lancet #MedicalEducation

🧠 Three major stroke trials published in JAMA this week may reshape adjunctive reperfusion strategies in acute ischemic stroke.

🔹 TNK-PLUS: Tenecteplase before thrombectomy in late-window stroke showed no added functional benefit. 🔹 CHOICE-2: Intra-arterial alteplase after successful thrombectomy improved excellent neurological recovery, though mortality signals warrant caution. 🔹 INSTANT: Early tirofiban after inadequate tenecteplase response significantly improved 90-day outcomes in non-large vessel occlusion stroke.

Together, these studies highlight a growing shift from merely reopening arteries toward optimizing microvascular reperfusion and tissue recovery.

🧬 Tumours are not just masses of cells—they are organized ecosystems.

A remarkable Nature study by Zhang et al. mapped >10 million spatial transcriptomes across cancers and identified 9 conserved "spatial ecotypes" within the tumour microenvironment. Even more striking: these ecotypes could be detected non-invasively from plasma cell-free DNA using deep learning.

Higher SE7/SE8 predicted better immunotherapy outcomes, while SE4 forecast resistance and poorer survival. A powerful step toward blood-based spatial oncology and precision immunotherapy. 🚀🩸🔬

Zhang W, Brown EL, Usmani A, et al. Nature. 2026. doi:10.1038/s41586-026-10452-4

🧠💤 Can the unconscious brain still process meaning?

A remarkable Nature study used Neuropixels recordings from the human hippocampus during general anesthesia and found preserved oddball detection, semantic encoding, syntactic processing, and even prediction of upcoming words.

The anesthetized brain was not silent—it adapted, learned, and contextualized language despite loss of consciousness. These findings challenge classical theories tightly linking higher cognition to conscious awareness.

Katlowitz KA et al. Nature. 2026. https://doi.org/10.1038/s41586-026-10448-0 🎙️

A fascinating Lancet RCT shows once-weekly semaglutide may redefine alcohol use disorder treatment. 🎯

In 108 adults with AUD and obesity, semaglutide reduced heavy drinking days by –13.7 percentage points vs placebo (p=0.0015) and improved craving, consumption, and biomarkers. 📉

With an NNT of ~4.3 and a manageable safety profile, GLP-1 therapy signals a shift from abstinence to precision harm reduction. 💡

Efficacy. Safety. Meaningful impact.

Is this the beginning of a new era in addiction medicine? 🧠💉

What does it take to be remembered for 3,000 years? 🏺

Meet Imhotep—chancellor, architect of the Step Pyramid, and later revered as a god of healing. From stone structures that defy time to ideas that shaped medicine and myth, his legacy is both historical and philosophical.

As highlighted in early narratives, he was not just a builder of monuments—but a builder of meaning.

A timeless reminder: true impact is not just what we create—but what endures. ✨

#GreatDoctors #HistoryOfMedicine #Innovation #AncientWisdom #Leadership

❤️ New in Circulation: the 2026 AHA Dietary Guidance to Improve Cardiovascular Health distills prevention into 9 elegant features—maintain healthy weight, emphasize vegetables/fruits, choose whole grains, favor healthier proteins and unsaturated fats, minimize ultraprocessed foods, added sugars, and sodium, and avoid starting alcohol for health. Food, here, is not garnish; it is strategy. 🥗🌾🩺 #Cardiology #Prevention #Nutrition

🧬⚠️ Genes. Toxins. Tumors.

A compelling Nature Medicine study uncovers how the exposome—our lifetime environmental exposures—leaves epigenetic fingerprints linked to early-onset colorectal cancer.

🚜 A striking signal: picloram exposure shows consistent association across cohorts and real-world US data. 📊 Reinforces known risks (smoking, diet, education) while revealing novel environmental drivers.

💡 The message is clear: cancer prevention may begin far upstream—in policy, environment, and early-life exposures.

#ColorectalCancer #Exposome #Epigenetics #PrecisionMedicine #PublicHealth

Can AI think like a physician? 🧠🤖

A landmark Science 2026 study shows LLMs outperform physicians in structured diagnostic reasoning across NEJM cases and real-world emergency scenarios. 📊

Accuracy gains were striking—especially in early triage where uncertainty is highest. Yet, the story is not replacement, but partnership. 🤝

The real challenge now: translating benchmark brilliance into safe, equitable, real-world care. ⚖️

AI is no longer a tool—it's becoming a colleague. The question is: how do we train, trust, and integrate it? 🚀